Save your place

Sign in to WhoBought

Please try again later.

Denali Therapeutics Inc. (DNLI) institutional ownership

Latest close $23.11 Jul 24, 2026
Market cap$2.0B 52-week range SectorHealthcare
Funds holding · Q1 2026
235
reported DNLI position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
150 buyers · 85 sellers

Denali Therapeutics Inc. (DNLI) price and institutional activity

Dates

Q1 2026

$0 bought by 150 investors
Adar1 Capital Management, LLCVestal Point Capital, LP +148 more
$0 sold by 85 investors
NorgesPoint72 Asset Management, L.P. +83 more
Bought Sold Totals per quarter; hover a bar for the names.

Denali Therapeutics Inc. (DNLI) institutional activity · 235

Investor Type Est. change Change Δ Own Date
Norges · Exited
Change −5.1M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −5.1M −100.0% Q1 2026
Adar1 Capital Management, LLC · Added
Change +1.8M Date Q1 2026
Adar1 Capital Management, LLC Added· Q1 2026 +1.8M Q1 2026
Point72 Asset Management, L.P. · Exited
Change −1.7M Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −1.7M −100.0% Q1 2026
FMR LLC · Reduced
Change −1.5M Δ Own −25.0% Date Q1 2026
FMR LLC Reduced· Q1 2026 −1.5M −25.0% Q1 2026
T. Rowe Price Associates · Reduced
Change −1.5M Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −1.5M Q1 2026
Vestal Point Capital, LP · Added
Change +1.3M Date Q1 2026
Vestal Point Capital, LP Added· Q1 2026 +1.3M Q1 2026
T. Rowe Price Investment Management, Inc. · Added
Change +1.3M Date Q1 2026
T. Rowe Price Investment Management, Inc. Added· Q1 2026 +1.3M Q1 2026
Pictet Asset Management Holding SA · Added
Change +1.2M Date Q1 2026
Pictet Asset Management Holding SA Added· Q1 2026 +1.2M Q1 2026
Capital Research Global Investors · Reduced
Change −1.2M Δ Own −32.6% Date Q1 2026
Capital Research Global Investors Reduced· Q1 2026 −1.2M −32.6% Q1 2026
Artisan Partners Limited Partnership · New
Change +1.1M Date Q1 2026
Artisan Partners Limited Partnership New· Q1 2026 +1.1M Q1 2026
Alyeska Investment Group, L.P. · Added
Change +1.1M Date Q1 2026
Alyeska Investment Group, L.P. Added· Q1 2026 +1.1M Q1 2026
Exoduspoint Capital Management, LP · Exited
Change −1.0M Δ Own −100.0% Date Q1 2026
Exoduspoint Capital Management, LP Exited· Q1 2026 −1.0M −100.0% Q1 2026
Millennium Management LLC · Added
Change +888K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +888K Q1 2026
Clearstead Advisors, LLC · New
Change +738K Date Q1 2026
Clearstead Advisors, LLC New· Q1 2026 +738K Q1 2026
Defilade Capital Management, L.P. · Added
Change +703K Date Q1 2026
Defilade Capital Management, L.P. Added· Q1 2026 +703K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 235

Famous investor activity in Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Inc. (DNLI) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Flatley Jay T. · Director 2 operations 26K
Owned 19K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Flatley Jay T. Director 2 operations 26K 19K Jun 3, 2026 Jun 5, 2026
Klein Peter S. · Director 2 operations 26K
Owned 19K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Klein Peter S. Director 2 operations 26K 19K Jun 3, 2026 Jun 5, 2026
Krognes Steve E. · Director 2 operations 26K
Owned 19K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Krognes Steve E. Director 2 operations 26K 19K Jun 3, 2026 Jun 5, 2026
Schenkein David P. · Director 2 operations 26K
Owned 19K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Schenkein David P. Director 2 operations 26K 19K Jun 3, 2026 Jun 5, 2026
Thornberry Nancy · Director 2 operations 26K
Owned 19K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Thornberry Nancy Director 2 operations 26K 19K Jun 3, 2026 Jun 5, 2026
Van Hauwermeiren Timothy · Director 2 operations 26K
Owned 19K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Van Hauwermeiren Timothy Director 2 operations 26K 19K Jun 3, 2026 Jun 5, 2026
Cook Jennifer E. · Director 2 operations 26K
Owned 19K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Cook Jennifer E. Director 2 operations 26K 19K Jun 3, 2026 Jun 5, 2026
Baker Bros. Advisors LP · Director 4 operations 51K
Owned 19K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Baker Bros. Advisors LP Director 4 operations 51K 19K Jun 3, 2026 Jun 5, 2026
Watts Ryan J. · Director, Officer Sell −$581K
Price $16.50 Qty −35K Owned 297K Trade date Jan 6, 2026 Filed date Jan 8, 2026
Watts Ryan J. Director, Officer Sell $16.50 −35K −$581K 297K Jan 6, 2026 Jan 8, 2026
Schuth Alexander O. · Officer Sell −$284K
Price $16.50 Qty −17K Owned 283K Trade date Jan 6, 2026 Filed date Jan 8, 2026
Schuth Alexander O. Officer Sell $16.50 −17K −$284K 283K Jan 6, 2026 Jan 8, 2026
Schuth Alexander O. · Officer 2 operations 231K
Owned 173K Trade date Jan 3, 2026 Filed date Jan 5, 2026
Schuth Alexander O. Officer 2 operations 231K 173K Jan 3, 2026 Jan 5, 2026
Watts Ryan J. · Director, Officer 2 operations 316K
Owned 237K Trade date Jan 3, 2026 Filed date Jan 5, 2026
Watts Ryan J. Director, Officer 2 operations 316K 237K Jan 3, 2026 Jan 5, 2026
Baker Julian · Director 2 operations $40M
Price $17.49 Qty 2.3M Owned 2.3M Trade date Dec 11, 2025 Filed date Dec 15, 2025
Baker Julian Director 2 operations $17.49 2.3M $40M 2.3M Dec 11, 2025 Dec 15, 2025
Van Hauwermeiren Timothy · Director 2 operations 43K
Owned 32K Trade date Nov 4, 2025 Filed date Nov 6, 2025
Van Hauwermeiren Timothy Director 2 operations 43K 32K Nov 4, 2025 Nov 6, 2025
Watts Ryan J. · Director, Officer Gift (G) -50K
Owned 2.2M Trade date Sep 3, 2025 Filed date Sep 5, 2025
Watts Ryan J. Director, Officer Gift (G) -50K 2.2M Sep 3, 2025 Sep 5, 2025
15 of 19
15 of 19 Sign in to continue to older insider transactions.

Denali Therapeutics Inc. (DNLI) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Baillie Gifford & Co 14.3M
% of shares outstanding 10.3% Filing date Jan 30, 2024
Baillie Gifford & Co 14.3M 10.3% Jan 30, 2024
T. Rowe Price Investment Management, Inc. 16.2M
% of shares outstanding 10.2% Filing date Jul 8, 2026
T. Rowe Price Investment Management, Inc. 16.2M 10.2% Jul 8, 2026
Blackrock, Inc. 13.8M
% of shares outstanding 9.6% Filing date Nov 8, 2024
Blackrock, Inc. 13.8M 9.6% Nov 8, 2024
BlackRock Inc. 11.5M
% of shares outstanding 8.4% Filing date Jan 25, 2024
BlackRock Inc. 11.5M 8.4% Jan 25, 2024
Vanguard Group Inc 10.8M
% of shares outstanding 7.8% Filing date Feb 13, 2024
Vanguard Group Inc 10.8M 7.8% Feb 13, 2024
Wellington Management Group LLP 10.7M
% of shares outstanding 7.5% Filing date Nov 8, 2024
Wellington Management Group LLP 10.7M 7.5% Nov 8, 2024
FMR LLC 10.1M
% of shares outstanding 7.1% Filing date Nov 12, 2024
FMR LLC 10.1M 7.1% Nov 12, 2024
Capital Research Global Investors 7.9M
% of shares outstanding 5.5% Filing date Nov 12, 2024
Capital Research Global Investors 7.9M 5.5% Nov 12, 2024
8 of 14

Denali Therapeutics Inc. (DNLI) ownership FAQ

Who owns DNLI?

235 reporting institutions disclosed DNLI position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.